Search Results - "Minzi, Omary M. S."

Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania by Fimbo, Adam, Mwalwisi, Yonah H., Mwamwitwa, Kissa, Matiko, Damas, Mfinanga, Elirehema, Lyimo, Johnson, Sabasaba, Amon, Missago, Seth, Bukundi, Elias, Gotora, Goodluck, Respick, Dorice, Nkayamba, Alex, Masunga, Emmanuel, Mnkugwe, Rajabu Hussein, Kunambi, Peter P., Munishi, Castory, Musanhu, Christine Chiedza, Minzi, Omary M. S., Mlugu, Eulambius M.

“…Tanzania adopted a Dolutegravir (DTG)-based regimen as first-line treatment in 2019 following the World Health Organization recommendation. Data on the DTG…”
Get full text

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women by Mutagonda, Ritah F, Kamuhabwa, Appolinary A R, Minzi, Omary M S, Massawe, Siriel N, Asghar, Muhammad, Homann, Manijeh V, Färnert, Anna, Aklillu, Eleni

“…Pregnancy has considerable effects on the pharmacokinetic properties of drugs used to treat uncomplicated Plasmodium falciparum malaria. The role of…”
Get full text

Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin by Minzi, Omary M. S, Lyimo, Tatu E, Furia, Francis F, Marealle, Alphonce I, Kilonzi, Manase, Bwire, George M, Malichewe, Christina

“…Abstract Background Cisplatin is an important drug in the treatment of various Cancers. However, this drug causes nephrotoxicity that is linked to electrolyte…”
Get full text

Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women by Mutagonda, Ritah F, Kamuhabwa, Appolinary A R, Minzi, Omary M S, Massawe, Siriel N, Maganda, Betty A, Aklillu, Eleni

“…Day 7 plasma concentrations of lumefantrine (LF) can serve as a marker to predict malaria treatment outcome in different study populations. Two main cut-off…”
Get full text

Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations by Mutagonda, Ritah F, Minzi, Omary M S, Massawe, Siriel N, Asghar, Muhammad, Färnert, Anna, Kamuhabwa, Appolinary A R, Aklillu, Eleni

“…Pregnancy and pharmacogenetics variation alter drug disposition and treatment outcome. The objective of this study was to investigate the effect of pregnancy…”
Get full text

Adoption of the new antimalarial drug policy in Tanzania – a cross‐sectional study in the community by Eriksen, Jaran, Nsimba, Stephen E. D., Minzi, Omary M. S., Sanga, Anku J., Petzold, Max, Gustafsson, Lars L., Warsame, Marian Y., Tomson, Göran

“…Summary Objective  To assess the diffusion of the change of first line antimalarial drug from chloroquine (CQ) to sulphadoxine/pyrimethamine (SP) at household…”
Get full text

The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment by Maganda, Betty A, Ngaimisi, Eliford, Kamuhabwa, Appolinary A R, Aklillu, Eleni, Minzi, Omary M S

“…HIV-malaria co-infected patients in most parts of sub-Saharan Africa are treated with both artemether-lumefantrine (AL) and efavirenz (EFV) or nevirapine…”
Get full text

Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations by Marwa, Karol J, Schmidt, Theresa, Sjögren, Maria, Minzi, Omary M S, Kamugisha, Erasmus, Swedberg, Göte

“…Artemisinin-based combinations currently recommended for treatment of uncomplicated Plasmodium falciparum malaria in many countries of sub-Saharan Africa are…”
Get full text

Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania by Mghamba, Frida William, Minzi, Omary M S, Massawe, Augustine, Sasi, Philip

“…Adherence to antiretroviral drugs in the treatment of paediatric HIV infection is complicated because of many factors including stigma and drug intake…”
Get full text

Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy by Maganda, Betty A, Minzi, Omary M S, Kamuhabwa, Appolinary A R, Ngasala, Billy, Sasi, Philip G

“…Malaria and HIV infections are both highly prevalent in sub-Saharan Africa, with HIV-infected patients being at higher risks of acquiring malaria. The majority…”
Get full text

Prevalence and Correlates of Lymphatic Filariasis Infection and Its Morbidity Following Mass Ivermectin and Albendazole Administration in Mkinga District, North-Eastern Tanzania by Fimbo, Adam M, Minzi, Omary M S, Mmbando, Bruno P, Barry, Abbie, Nkayamba, Alex F, Mwamwitwa, Kissa W, Malishee, Alpha, Seth, Misago D, Makunde, Williams H, Gurumurthy, Parthasarathi, Lusingu, John P A, Kamuhabwa, Appolinary A R, Aklillu, Eleni

“…Lymphatic filariasis (LF) is a neglected tropical disease targeted for elimination as public health problem through morbidity management and preventive annual…”
Get full text

Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product by Minzi, Omary M S, Marealle, Ignace A, Shekalaghe, Seif, Juma, Omar, Ngaimisi, Eliford, Chemba, Mwajuma, Rutaihwa, Mastidia, Abdulla, Salim, Sasi, Philip

“…Existence of anti-malarial generic drugs with low bioavailability marketed on sub-Saharan Africa raises a concern on patients achieving therapeutic…”
Get full text

Pharmacokinetics of piperaquine and its association with intermittent malaria preventive therapy outcomes during pregnancy by Mlugu, Eulambius M, Minzi, Omary M S, Johansson, Mats, Kamuhabwa, Appolinary A R, Aklillu, Eleni

“…Dihydroartemisinin-piperaquine (DHP) recently showed superior effectiveness over sulfadoxine-pyrimethamine for malaria intermittent preventive treatment in…”
Get full text

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study by Fimbo, Adam M, Mnkugwe, Rajabu Hussein, Mlugu, Eulambius Mathias, Kunambi, Peter P, Malishee, Alpha, Minzi, Omary M S, Kamuhabwa, Appolinary A R, Aklillu, Eleni

“…Preventive chemotherapy with ivermectin and albendazole (IA) in mass drug administration (MDA) programs for all at-risk populations is the core public health…”
Get full text

The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children by Sugiarto, Sri Riyati, Bwire, George M., Moore, Brioni R., Page-Sharp, Madhu, Manning, Laurens, Batty, Kevin T., Minzi, Omary M.S., Ngasala, Billy, Davis, Timothy M.E., Makani, Julie, Salman, Sam

“…Since there are inconsistent data relating to the effect of haemoglobinopathies on disposition of artemisinin antimalarial combination therapy, and none in…”
Get full text

Efficacy of standardized extract of Hibiscus sabdariffa L. (Malvaceae) in improving iron status of adults in malaria endemic area: A randomized controlled trial by Peter, Emanuel L., Rumisha, Susan F., Mashoto, Kijakazi O., Minzi, Omary MS, Mfinanga, Sayoki

“…Indigenous community of Mkuranga district have been using aqueous extract of H. sabdariffa L. for treating anemia. However, there have been neither safety nor…”
Get full text

Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania by Mugusi, Sabina F, Ngaimisi, Eliford, Janabi, Mohamed Y, Mugusi, Ferdinand M, Minzi, Omary M S, Sasi, Philip G, Bakari, Muhammad, Lindquist, Lars, Aklillu, Eleni, Sandstrom, Eric G

“…The aim of this study was to describe risk factors for mortality and clinical characteristics of HIV-infected patients with and without tuberculosis (TB)…”
Get more information

Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania by Joseph, Deokary, Kabanywanyi, Abdunoor M, Hulser, Ruth, Premji, Zulfiqarali, Minzi, Omary Ms, Mugittu, Kefas

“…Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malaria in 2006. Recently, there was an anecdotal report on high malaria…”
Get full text

Existence of antimalarial formulations with low bioavailability in Tanzania by Minzi, Omary M S, Massele, Amosy, Justin-Temu, Mary, Ericsson, Orjan, Gustafsson, Lars L

“…The main objective of this work was to assess the relative bioavailability of two tablet formulations containing sulfadoxine/pyrimethamine (SP) and marketed in…”
Get more information